Kilitch drugsKilitch drugs looks good fr a new high, bullish structure! After correction seems ready to move ahead!
12.15 INR
146.01 M INR
1.54 B INR
4.21 M
About KILITCH DRUGS INDIA LTD
Sector
Industry
CEO
Mukund Prataprai Mehta
Website
Headquarters
Mumbai
Founded
1978
ISIN
INE729D01010
FIGI
BBG000D4WJD5
Kilitch Drugs (India) Ltd. engages in the developing, manufacturing, and marketing of pharmaceuticals, medicinal chemical, and botanical products. Its products include OSD, parenteral, nasal, opthalmic, nutritional, medical devices, and cosmetics products. The company was founded by Pratap Keshavji Mehta in 1978 and is headquartered in Mumbai, India.
Kilitch Drugs India - LongKilitch Drugs India - CMP - 400 / Positional Trade
*Buy Range 400 to 405 ONLY / Stop Loss 345 in weekly candle closing*
*Target 1 - 450*
*Target 2 - 475*
*Target 3 - 500 / 550 / 600+*
Disclaimer: This is my view and for educational purpose only.
Wait for 200 SMA to come closer for long termWait for 200 SMA to come closer for long term. It can consolidate for some time near 200 SMA and then give a breakout.
KILITEC Drugs21/07/2024
KILITEC Drugs
CMP: 360.55
Entry above 365
Target: 380-430-470
SL :333
Information is only for study purpose
KILITCHBuy above:- 213
Stop Loss:- 165
Target:- 260
Time :- 45 trading days
The company is based on pharmaceutical company it is engaged in the manufacturing and sale of pharmaceutical products
KILITCH - C & H patternKILITCH
CMP 157
Spotted slightly late / Buying suggested on retracements 145-155
Stop 125
Target - Open
Logic :
Techncials:
C&H sort of pattern observed with Volume replicating the price pattern;
Breakout happened with huge volumes (@ 138).
Fundamentals:
Exponential growth in fundamental paramet
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of KILITCH is 397.30 INR — it has increased by 0.17% in the past 24 hours. Watch KILITCH DRUGS INDIA LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange KILITCH DRUGS INDIA LTD stocks are traded under the ticker KILITCH.
KILITCH stock has risen by 10.43% compared to the previous week, the month change is a 8.65% rise, over the last year KILITCH DRUGS INDIA LTD has showed a 12.04% increase.
KILITCH reached its all-time high on Feb 8, 2024 with the price of 470.00 INR, and its all-time low was 17.00 INR and was reached on Jun 13, 2013. View more price dynamics on KILITCH chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
KILITCH stock is 3.37% volatile and has beta coefficient of 0.95. Track KILITCH DRUGS INDIA LTD stock price on the chart and check out the list of the most volatile stocks — is KILITCH DRUGS INDIA LTD there?
Today KILITCH DRUGS INDIA LTD has the market capitalization of 6.23 B, it has increased by 14.90% over the last week.
Yes, you can track KILITCH DRUGS INDIA LTD financials in yearly and quarterly reports right on TradingView.
KILITCH net income for the last quarter is 59.61 M INR, while the quarter before that showed 86.17 M INR of net income which accounts for −30.82% change. Track more KILITCH DRUGS INDIA LTD financial stats to get the full picture.
KILITCH DRUGS INDIA LTD dividend yield was 0.00% in 2023, and payout ratio reached 0.00%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of May 6, 2025, the company has 136 employees. See our rating of the largest employees — is KILITCH DRUGS INDIA LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KILITCH DRUGS INDIA LTD EBITDA is 235.65 M INR, and current EBITDA margin is 16.01%. See more stats in KILITCH DRUGS INDIA LTD financial statements.
Like other stocks, KILITCH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KILITCH DRUGS INDIA LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KILITCH DRUGS INDIA LTD technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KILITCH DRUGS INDIA LTD stock shows the buy signal. See more of KILITCH DRUGS INDIA LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.